Clinical Trial Update: Efficacy and Safety of ATX01 in Adult Patients With CIPN (Chemotherapy-induced Peripheral Neuropathy) [Phase 2]

View source ↗

Summary

This clinical trial update reports on the efficacy and safety of ATX01 in adult patients with chemotherapy-induced peripheral neuropathy in a Phase 2 study; the…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemotherapy-induced Peripheral Neuropathy

Drugs mentioned

• ATX01

Snippet

Sponsor: AlgoTherapeutix | Conditions: Chemotherapy-induced Peripheral Neuropathy | Phase 2 | Status: ACTIVE_NOT_RECRUITING